Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CalciMedica Inc CALC

CalciMedica, Inc. is a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses. The Company's technology targets the inhibition of CRAC channels to modulate the immune response and protect against tissue cell injury. Its lead product candidate is Auxora, a potent and selective intravenous (IV) formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The Company is conducting a Phase 2b trial (called CARPO - NCT04681066) for acute pancreatitis (AP) with systemic inflammatory response syndrome (SIRS), as well as supporting the ongoing Phase 1/2 asparaginase induced pancreatic toxicity (AIPT) study (called CRSPA - NCT04195347).


NDAQ:CALC - Post by User

Post by alphaflighton Nov 04, 2021 8:45am
264 Views
Post# 34085776

Graycliff's New Near-Surface Gold: 4.83 g/t over 3.0m

Graycliff's New Near-Surface Gold: 4.83 g/t over 3.0m
Graycliff Exploration Intersects Near-Surface Gold Mineralization Grading 4.83 g/t Over 3.0 Metres at Shakespeare Project, Ontario
TORONTO, ON – November 4, 2021 -  Graycliff Exploration Limited (the “Company” or “Graycliff”) (CSE: GRAY) (OTCQB: GRYCF) (FSE: GE0) is pleased to announce additional assay results from drilling on its Shakespeare Gold Project located on the prolific Canadian Shield near Sudbury, Ontario. The latest results are from the 2,200-metre Phase Two program that focused on defining the extent of gold mineralization proximal to the historic Miller where initial gold mining took place more than 100 years ago.
 
Drill Holes J-17-21 intersected two mineralized intervals seven (7) metres (“m”) apart with the higher interval returning 4.83 g/t gold (“Au”) over 3.0 m, including 13.40 g/t Au over 1.0 m. Drill Hole J-15-21 was terminated early after intersecting a fault. Significant intervals for holes J-15-21 to J-17-21 are detailed below:
Table 1 - Highlighted Results from Holes J-15-21 to J-17-21
 
“Thus far, the assay results from the Phase Two core drilling program continue to expand the defined strike length of the known gold mineralization proximal to the historic Miller shaft. We have now reported gold mineralization along a strike length of approximately 115 metres, and we have not yet defined a lower limit to the gold mineralization that includes significant gold values as well as visible gold in strongly veined and silicified schist with associated sulphide mineralization. As previously indicated by the Company’s CEO, we expect that our efforts to develop a 3D model for the geology, structure and gold mineralization close to where we are drilling will help us better define the structural and mineralogical parameters associated with the gold mineralization at Shakespeare. We also anticipate that our ongoing modelling will provide us with new “blue sky” targets along the six kilometres of general strike length. Based on our work to date, we see no reason for the gold mineralization to not continue well below the areas now being tested,” stated Bruce Durham, Technical Advisor and QP.
 
 
 
Qualified Person
Bruce Durham, P.Geo, is a Qualified Person, as that term is defined by Canadian regulatory guidelines under NI 43-101, and has read and approved the technical information contained in this press release.
About Graycliff Exploration Limited.
Graycliff Exploration is a mineral exploration company focused on its 1,025 hectares of prospective ground, located roughly 80 kilometres west of Sudbury on the prolific Canadian Shield. The Company's Shakespeare Project consists of one crown patented lease, two crown leases and 40 claims on a property associated with the historic Shakespeare Gold Mine, which operated from 1903 to 1907. Graycliff’s Baldwin Project is adjacent to the east and is comprised of 68 claims covering 1,500 hectares. This brings our total land package in the area to 2,525 hectares.
For more information, contact investor relations at investors@graycliffexploration.com
 
On Behalf of the Board of Directors,
 
James Macintosh
President and CEO
Graycliff Exploration Limited
 
Nicholas D Konkin
401 Bay Street, Suite 2702,
Toronto, Ontario
M5H2Y4 Canada
416 567 9087
<< Previous
Bullboard Posts
Next >>